Published in Clin Microbiol Rev on April 01, 2012
Comparison of the BD Veritor System for Flu A+B with the Alere BinaxNOW influenza A&B card for detection of influenza A and B viruses in respiratory specimens from pediatric patients. J Clin Microbiol (2014) 1.32
Can newly developed, rapid immunochromatographic antigen detection tests be reliably used for the laboratory diagnosis of influenza virus infections? J Clin Microbiol (2014) 0.98
Effect of Culture-Independent Diagnostic Tests on Future Emerging Infections Program Surveillance. Emerg Infect Dis (2015) 0.95
Replication-competent influenza A viruses expressing a red fluorescent protein. Virology (2014) 0.89
Approved Antiviral Drugs over the Past 50 Years. Clin Microbiol Rev (2016) 0.88
Clinical Evaluation of the Luminex NxTAG Respiratory Pathogen Panel. J Clin Microbiol (2016) 0.84
Mono- and quadri-subtype virus-like particles (VLPs) containing H10 subtype elicit protective immunity to H10 influenza in a ferret challenge model. Vaccine (2016) 0.81
Towards multitarget testing in molecular microbiology. Int J Microbiol (2013) 0.81
Multiplexed detection of viral infections using rapid in situ RNA analysis on a chip. Lab Chip (2015) 0.81
Effect of statin treatments on highly pathogenic avian influenza H5N1, seasonal and H1N1pdm09 virus infections in BALB/c mice. Future Virol (2012) 0.80
Improving Accuracy of Influenza-Associated Hospitalization Rate Estimates. Emerg Infect Dis (2015) 0.79
Respiratory viral testing: new frontiers in diagnostics and implications for antimicrobial stewardship. Virulence (2013) 0.77
Identification of novel compounds against an R294K substitution of influenza A (H7N9) virus using ensemble based drug virtual screening. Int J Med Sci (2015) 0.77
Sequence amplification via cell passaging creates spurious signals of positive adaptation in influenza virus H3N2 hemagglutinin. Virus Evol (2016) 0.76
Survey of influenza and other respiratory viruses diagnostic testing in US hospitals, 2012-2013. Influenza Other Respir Viruses (2016) 0.75
A Narrative Review of Influenza: A Seasonal and Pandemic Disease. Iran J Med Sci (2017) 0.75
Discovery of variant infectious salmon anaemia virus (ISAV) of European genotype in British Columbia, Canada. Virol J (2016) 0.75
Early administration of neuraminidase inhibitors in adult patients hospitalized for influenza does not benefit survival: a retrospective cohort study. Eur J Clin Microbiol Infect Dis (2017) 0.75
Loop-mediated isothermal amplification of DNA. Nucleic Acids Res (2000) 19.30
Swine influenza A (H1N1) infection in two children--Southern California, March-April 2009. MMWR Morb Mortal Wkly Rep (2009) 17.76
Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N Engl J Med (2009) 15.02
Time lines of infection and disease in human influenza: a review of volunteer challenge studies. Am J Epidemiol (2008) 10.02
Serum cross-reactive antibody response to a novel influenza A (H1N1) virus after vaccination with seasonal influenza vaccine. MMWR Morb Mortal Wkly Rep (2009) 9.94
Resistant influenza A viruses in children treated with oseltamivir: descriptive study. Lancet (2004) 8.62
Adamantane resistance among influenza A viruses isolated early during the 2005-2006 influenza season in the United States. JAMA (2006) 8.06
Evaluation of multiple test methods for the detection of the novel 2009 influenza A (H1N1) during the New York City outbreak. J Clin Virol (2009) 6.38
Rapid-test sensitivity for novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med (2009) 5.98
Antiviral agents for the treatment and chemoprophylaxis of influenza --- recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep (2011) 5.48
Surveillance for neuraminidase inhibitor resistance among human influenza A and B viruses circulating worldwide from 2004 to 2008. Antimicrob Agents Chemother (2008) 5.04
Oral oseltamivir treatment of influenza in children. Pediatr Infect Dis J (2001) 4.93
Determinants of immunity to influenza infection in man. Br Med Bull (1979) 4.62
Rapid antigen tests for diagnosis of pandemic (Swine) influenza A/H1N1. Clin Infect Dis (2009) 4.51
Evaluation of rapid influenza diagnostic tests for detection of novel influenza A (H1N1) Virus - United States, 2009. MMWR Morb Mortal Wkly Rep (2009) 4.50
Oseltamivir (Tamiflu) and its potential for use in the event of an influenza pandemic. J Antimicrob Chemother (2005) 3.53
Evidence for zanamivir resistance in an immunocompromised child infected with influenza B virus. J Infect Dis (1998) 3.47
Low sensitivity of rapid diagnostic test for influenza. Clin Infect Dis (2009) 3.31
Comparison of flocked and rayon swabs for collection of respiratory epithelial cells from uninfected volunteers and symptomatic patients. J Clin Microbiol (2006) 3.17
Detection of respiratory viruses by molecular methods. Clin Microbiol Rev (2008) 3.03
Evaluation of the Hexaplex assay for detection of respiratory viruses in children. J Clin Microbiol (2001) 2.94
Poor clinical sensitivity of rapid antigen test for influenza A pandemic (H1N1) 2009 virus. Emerg Infect Dis (2009) 2.86
Performance of influenza rapid point-of-care tests in the detection of swine lineage A(H1N1) influenza viruses. Influenza Other Respir Viruses (2009) 2.75
Lower clinical effectiveness of oseltamivir against influenza B contrasted with influenza A infection in children. Clin Infect Dis (2006) 2.72
Zanamivir-resistant influenza viruses with a novel neuraminidase mutation. J Virol (2009) 2.59
The early diversification of influenza A/H1N1pdm. PLoS Curr (2009) 2.44
Recovery of drug-resistant influenza virus from immunocompromised patients: a case series. J Infect Dis (2006) 2.43
Accuracy and interpretation of rapid influenza tests in children. Pediatrics (2007) 2.43
Role of the laboratory in diagnosis of influenza during seasonal epidemics and potential pandemics. J Infect Dis (2006) 2.41
Loop mediated isothermal amplification (LAMP): a new generation of innovative gene amplification technique; perspectives in clinical diagnosis of infectious diseases. Rev Med Virol (2008) 2.38
National disease burden of respiratory viruses detected in children by polymerase chain reaction. Pediatr Infect Dis J (2004) 2.32
Detection and identification of human influenza viruses by the polymerase chain reaction. J Virol Methods (1991) 2.29
Molecular mechanisms of influenza virus resistance to neuraminidase inhibitors. Virus Res (2004) 2.25
Role of cell culture for virus detection in the age of technology. Clin Microbiol Rev (2007) 2.12
Detection of molecular markers of drug resistance in 2009 pandemic influenza A (H1N1) viruses by pyrosequencing. Antimicrob Agents Chemother (2009) 2.09
High levels of adamantane resistance among influenza A (H3N2) viruses and interim guidelines for use of antiviral agents--United States, 2005-06 influenza season. MMWR Morb Mortal Wkly Rep (2006) 1.91
Natural variation can significantly alter the sensitivity of influenza A (H5N1) viruses to oseltamivir. Antimicrob Agents Chemother (2006) 1.85
Likelihood that an unsubtypeable influenza A virus result obtained with the Luminex xTAG respiratory virus panel is indicative of infection with novel A/H1N1 (swine-like) influenza virus. J Clin Microbiol (2009) 1.82
Multiplex PCR and emerging technologies for the detection of respiratory pathogens. Clin Infect Dis (2011) 1.82
Serologic assays for influenza surveillance, diagnosis and vaccine evaluation. Expert Rev Anti Infect Ther (2011) 1.81
Development of a real-time RT-PCR for the detection of swine-lineage influenza A (H1N1) virus infections. J Clin Virol (2009) 1.78
Pyrosequencing as a tool to detect molecular markers of resistance to neuraminidase inhibitors in seasonal influenza A viruses. Antiviral Res (2008) 1.78
Design and validation of real-time reverse transcription-PCR assays for detection of pandemic (H1N1) 2009 virus. J Clin Microbiol (2009) 1.76
Genomic signature and mutation trend analysis of pandemic (H1N1) 2009 influenza A virus. PLoS One (2010) 1.75
Role of rapid immunochromatographic antigen testing in diagnosis of influenza A virus 2009 H1N1 infection. J Clin Microbiol (2009) 1.74
Laboratory surge response to pandemic (H1N1) 2009 outbreak, New York City metropolitan area, USA. Emerg Infect Dis (2010) 1.67
Host cell selection of influenza neuraminidase variants: implications for drug resistance monitoring in A(H1N1) viruses. Antiviral Res (2009) 1.66
Performance of rapid influenza diagnostic tests during two school outbreaks of 2009 pandemic influenza A (H1N1) virus infection - Connecticut, 2009. MMWR Morb Mortal Wkly Rep (2009) 1.66
Detection of E119V and E119I mutations in influenza A (H3N2) viruses isolated from an immunocompromised patient: challenges in diagnosis of oseltamivir resistance. Antimicrob Agents Chemother (2010) 1.63
Sensitivity and specificity of serologic assays for detection of human infection with 2009 pandemic H1N1 virus in U.S. populations. J Clin Microbiol (2011) 1.62
Dual infections by influenza A/H3N2 and B viruses and by influenza A/H3N2 and A/H1N1 viruses during winter 2007, Corsica Island, France. J Clin Virol (2008) 1.62
Evaluation of a rapid molecular algorithm for detection of pandemic influenza A (H1N1) 2009 virus and screening for a key oseltamivir resistance (H275Y) substitution in neuraminidase. J Clin Virol (2009) 1.58
Rapid quantitation of neuraminidase inhibitor drug resistance in influenza virus quasispecies. Antivir Ther (2008) 1.55
Frequency of drug-resistant viruses and virus shedding in pediatric influenza patients treated with neuraminidase inhibitors. Clin Infect Dis (2011) 1.52
Advances in the laboratory diagnosis of viral respiratory disease. Pediatr Infect Dis J (2004) 1.51
Detection of 11 common viral and bacterial pathogens causing community-acquired pneumonia or sepsis in asymptomatic patients by using a multiplex reverse transcription-PCR assay with manual (enzyme hybridization) or automated (electronic microarray) detection. J Clin Microbiol (2008) 1.51
Deep sequencing reveals mixed infection with 2009 pandemic influenza A (H1N1) virus strains and the emergence of oseltamivir resistance. J Infect Dis (2011) 1.45
Dual resistance to adamantanes and oseltamivir among seasonal influenza A(H1N1) viruses: 2008-2010. J Infect Dis (2011) 1.42
Rapid detection of influenza A pandemic (H1N1) 2009 virus neuraminidase resistance mutation H275Y by real-time reverse transcriptase PCR. J Clin Microbiol (2010) 1.42
H1N1 influenza: contact investigation burden because of failure to institute influenza precautions in patients with negative rapid influenza diagnostic test results. Infect Control Hosp Epidemiol (2010) 1.38
Characteristics of patients with oseltamivir-resistant pandemic (H1N1) 2009, United States. Emerg Infect Dis (2011) 1.38
Detection of human influenza A viruses by loop-mediated isothermal amplification. J Clin Microbiol (2005) 1.37
Detection of respiratory viruses using non-molecular based methods. J Clin Virol (2007) 1.37
Detecting 2009 pandemic influenza A (H1N1) virus infection: availability of diagnostic testing led to rapid pandemic response. Clin Infect Dis (2011) 1.36
Nucleic acid amplification-based diagnosis of respiratory virus infections. Expert Rev Anti Infect Ther (2010) 1.35
Clinical performance of a rapid influenza test and comparison of nasal versus throat swabs to detect 2009 pandemic influenza A (H1N1) infection in Thai children. Pediatr Infect Dis J (2010) 1.32
Evaluation of new rapid antigen test for detection of pandemic influenza A/H1N1 2009 virus. J Clin Microbiol (2010) 1.32
Systematic review of influenza resistance to the neuraminidase inhibitors. BMC Infect Dis (2011) 1.31
Rapid semiautomated subtyping of influenza virus species during the 2009 swine origin influenza A H1N1 virus epidemic in Milwaukee, Wisconsin. J Clin Microbiol (2009) 1.30
Clinical performance of the 3M Rapid Detection Flu A+B Test compared to R-Mix culture, DFA and BinaxNOW Influenza A&B Test. J Clin Virol (2009) 1.27
Development of a reverse transcription-loop-mediated isothermal amplification assay for detection of pandemic (H1N1) 2009 virus as a novel molecular method for diagnosis of pandemic influenza in resource-limited settings. J Clin Microbiol (2010) 1.26
Use of rapid influenza diagnostic tests under field conditions as a screening tool during an outbreak of the 2009 novel influenza virus: practical considerations. J Clin Virol (2010) 1.25
Detection of molecular markers of antiviral resistance in influenza A (H5N1) viruses using a pyrosequencing method. Antimicrob Agents Chemother (2009) 1.23
Visual detection of pandemic influenza A H1N1 Virus 2009 by reverse-transcription loop-mediated isothermal amplification with hydroxynaphthol blue dye. J Virol Methods (2010) 1.22
Rapid detection and identification of human adenovirus species by adenoplex, a multiplex PCR-enzyme hybridization assay. J Clin Microbiol (2004) 1.18
Resistance to anti-influenza drugs: adamantanes and neuraminidase inhibitors. Expert Rev Anti Infect Ther (2006) 1.16
Cluster of oseltamivir-resistant 2009 pandemic influenza A (H1N1) virus infections on a hospital ward among immunocompromised patients--North Carolina, 2009. J Infect Dis (2011) 1.15
Diagnostic accuracy of an allele-specific reverse transcriptase-PCR assay targeting the H275Y oseltamivir resistant mutation in 2009 pandemic influenza A/H1N1 virus. J Clin Virol (2010) 1.12
Influenza antiviral resistance testing in new york and wisconsin, 2006 to 2008: methodology and surveillance data. J Clin Microbiol (2009) 1.10
Mutability in the matrix gene of novel influenza A H1N1 virus detected using a FRET probe-based real-time reverse transcriptase PCR assay. J Clin Microbiol (2009) 1.10
Oseltamivir-resistant influenza A and B viruses pre- and postantiviral therapy in children and young adults with cancer. Pediatr Infect Dis J (2011) 1.10
Detection of antiviral resistance and genetic lineage markers in influenza B virus neuraminidase using pyrosequencing. Antiviral Res (2009) 1.09
Introduction of a Novel Swine-Origin Influenza A (H1N1) Virus into Milwaukee, Wisconsin in 2009. Viruses (2009) 1.09
A comparison of pyrosequencing and neuraminidase inhibition assays for the detection of oseltamivir-resistant pandemic influenza A(H1N1) 2009 viruses. Antiviral Res (2011) 1.08
Selection for resistance to oseltamivir in seasonal and pandemic H1N1 influenza and widespread co-circulation of the lineages. Int J Health Geogr (2010) 1.06
Diagnostic tests for influenza infection. Curr Opin Pediatr (2011) 1.05
Development of a novel real-time reverse-transcriptase PCR method for the detection of H275Y positive influenza A H1N1 isolates. J Virol Methods (2009) 1.04
Loop-mediated isothermal amplification for influenza A (H5N1) virus. Emerg Infect Dis (2007) 1.04
Unique finding of a 2009 H1N1 influenza virus-positive clinical sample suggests matrix gene sequence variation. J Clin Microbiol (2009) 1.03
Emerging molecular assays for detection and characterization of respiratory viruses. Clin Lab Med (2009) 1.02
Reversion of influenza A (H3N2) virus from amantadine resistant to amantadine sensitive by further reassortment in Japan during the 2006-to-2007 influenza season. J Clin Microbiol (2008) 1.02
Epidemiologic Observations from Passive and Targeted Surveillance during the First Wave of the 2009 H1N1 Influenza Pandemic in Milwaukee, WI. Viruses (2010) 1.00
Antiviral resistance and impact on viral replication capacity: evolution of viruses under antiviral pressure occurs in three phases. Handb Exp Pharmacol (2009) 1.00
Strengths and weaknesses of FDA-approved/cleared diagnostic devices for the molecular detection of respiratory pathogens. Clin Infect Dis (2011) 0.98
The role of community molecular diagnostics laboratories in the H1N1 pandemic. J Mol Diagn (2009) 0.98
Multiplex assay for simultaneously typing and subtyping influenza viruses by use of an electronic microarray. J Clin Microbiol (2008) 0.98
Time-dependent sensitivity of a rapid antigen test in patients with 2009 H1N1 influenza. J Clin Microbiol (2011) 0.97
Viral upper respiratory tract infection and otitis media complication in young children. Clin Infect Dis (2008) 3.75
Clinical and epidemiologic characteristics of children hospitalized with 2009 pandemic H1N1 influenza A infection. Pediatr Infect Dis J (2010) 2.07
Detection of 11 common viral and bacterial pathogens causing community-acquired pneumonia or sepsis in asymptomatic patients by using a multiplex reverse transcription-PCR assay with manual (enzyme hybridization) or automated (electronic microarray) detection. J Clin Microbiol (2008) 1.51
Whole genome sequencing and evolutionary analysis of human respiratory syncytial virus A and B from Milwaukee, WI 1998-2010. PLoS One (2011) 1.42
Rapid semiautomated subtyping of influenza virus species during the 2009 swine origin influenza A H1N1 virus epidemic in Milwaukee, Wisconsin. J Clin Microbiol (2009) 1.30
Persistence of adenovirus nucleic acids in nasopharyngeal secretions: a diagnostic conundrum. Pediatr Infect Dis J (2010) 1.24
Phylogeography of the spring and fall waves of the H1N1/09 pandemic influenza virus in the United States. J Virol (2010) 1.23
Rapid detection and identification of human adenovirus species by adenoplex, a multiplex PCR-enzyme hybridization assay. J Clin Microbiol (2004) 1.18
Introduction of a Novel Swine-Origin Influenza A (H1N1) Virus into Milwaukee, Wisconsin in 2009. Viruses (2009) 1.09
Simultaneous Detection of CDC Category "A" DNA and RNA Bioterrorism Agents by Use of Multiplex PCR & RT-PCR Enzyme Hybridization Assays. Viruses (2009) 1.08
Molecular diagnosis of respiratory viruses. Future Microbiol (2010) 1.07
Epidemiologic Observations from Passive and Targeted Surveillance during the First Wave of the 2009 H1N1 Influenza Pandemic in Milwaukee, WI. Viruses (2010) 1.00
Multiplex assay for simultaneously typing and subtyping influenza viruses by use of an electronic microarray. J Clin Microbiol (2008) 0.98
Distribution of respiratory syncytial virus subtypes A and B among infants presenting to the emergency department with lower respiratory tract infection or apnea. Pediatr Infect Dis J (2013) 0.98
The Influenza Primer Design Resource: a new tool for translating influenza sequence data into effective diagnostics. Influenza Other Respir Viruses (2008) 0.95
A vancomycin-heparin lock solution for prevention of nosocomial bloodstream infection in critically ill neonates with peripherally inserted central venous catheters: a prospective, randomized trial. Pediatrics (2005) 0.92
The 2009 COID recommendations for RSV prophylaxis: issues of efficacy, cost, and evidence-based medicine. Pediatrics (2009) 0.84
Current methods for the rapid diagnosis of bioterrorism-related infectious agents. Pediatr Clin North Am (2006) 0.81
H1N1 hemagglutinin-inhibition seroprevalence in Emergency Department Health Care workers after the first wave of the 2009 influenza pandemic. Pediatr Emerg Care (2011) 0.81
Genome sequencing and phylogenetic analysis of 39 human parainfluenza virus type 1 strains isolated from 1997-2010. PLoS One (2012) 0.80
Analytical reactivity of 13 commercially available rapid influenza diagnostic tests with H3N2v and recently circulating influenza viruses. Influenza Other Respir Viruses (2014) 0.77